Portfolio company
Panacos
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops small molecule antiviral drugs to treat patients with human immunodeficiency virus and other serious infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Enanta
This biotechnology company develops small molecule medicines to treat viral infections and immunological diseases for patients with serious medical conditions.
Eradivir
This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.
Antios Therapeutics
This clinical-stage biopharmaceutical company develops antiviral therapies to treat and cure patients with chronic hepatitis B virus infections.
Corus Pharmaceuticals
This company develops biopharmaceutical medicines to treat patients with HIV, viral hepatitis, cancer and inflammatory diseases.
Halo Therapeutics
This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.
Pharmasset
This biopharma company develops medicines for patients suffering from HIV, viral hepatitis, cancer, and inflammatory diseases.
Pano Therapeautics
This biotechnology company develops small molecule drugs targeting mitochondrial ion channels to treat neurodevelopmental disorders and complex diseases of aging.
Aelix
The company develops therapeutic vaccines to treat and eradicate human immunodeficiency virus infections for patients.
